Molecular Characterization of Pontocerebellar Hypoplasia
Molecular Characterization of Pontocerebellar Hypoplasia
批准号:
10590583
负责人:
JOSEPH G GLEESON
金额:
$47.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-08-15 至 2027-03-31
关键词:
AffectApoptosisAppearanceAttentionAwardBasal GangliaBrainBrain DiseasesBrain StemCandidate Disease GeneCell modelCell physiologyCellsCerebellumCerebral cortexChildhoodClinicalClinical TrialsDNADNA DamageDataDatabasesDefectDeglutitionDevelopmentDiseaseEncephalopathiesEnrollmentEye MovementsFamilyFundingFutureGene MutationGenesGeneticGenomicsGenotoxic StressGenotypeGoalsHumanImpairmentIndividualInheritedKnock-in MouseLeadLoss of HeterozygosityMeiosisMessenger RNAMethodsMiddle EastModificationMolecularMolecular DiagnosisMusMutateMutationNerve DegenerationNeurodevelopmental DisorderNeurologicNeuronsNuclearNuclear AccidentsOrganoidsParalysedPathogenicityPathway interactionsPatientsPerinatalPhenotypePontine structurePontocerebellar hypoplasiaProtein BiosynthesisProteinsPsyche structurePublishingRNARNA ProcessingRNA SplicingResourcesRibonuclease HRiskSecureSeriesSmall Nuclear RNASpinal CordSpliceosomesStructureSusceptibility GeneSyndromeTP53 geneTermination of pregnancyTestingTransfer RNAValidationVariantWorkage relatedbrain magnetic resonance imagingcohortconsanguineous familydisease mechanisms studyexome sequencinggene discoverygenome integritygenome sequencinghindbrainin vitro testingin vivoin vivo Modelinfancyinsightinterestknockout geneneuralneurodevelopmentneuron apoptosisneuron lossnoveloverexpressionradiological imagingrecruitresponsetranscriptomicsventilationvirulence genewhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Pontocerebellar hypoplasia (PCH) is a heterogeneous group of mostly recessive pediatric brain
disorders that show features of both impaired neurodevelopment and presence of neurodegeneration.
PCH is characterized by severe age-dependent neurological impairment, and notable radiographic
volume loss of the pons and cerebellum with loss of brainstem and cerebellar neurons. Currently
there are 32 genes known mutated in PCH, but still more genes await to be discovered, and molecular
mechanisms are poorly understood. Some of the genes implicate key steps in protein synthesis and
genomic integrity including tRNA and mRNA splicing, suggesting disruption to homeostatic cellular
functions, but many questions remain: 1] How many genetic subtypes remain to be discovered? 2]
Why do loss of broadly expressed genes predispose specifically to neurons? 3] Are there convergent
molecular pathways for PCH? Over the past 5 years, we have: 1] Grown our unique cohort of PCH
patients, containing 248 families including 132 still without a molecular cause. 2] Applied a range of
genomics and transcriptomics methods to uncovered mutations in several novel genes including
TOE1, TBC1D23, PRP17 and PPIL1 leading to specific PCH subtypes. 3] Revealed defects in RNA
splicing and genome integrity as underlying causes. 4] Uncovered the first spliceosome protein
mutations. 5] Revealed new genotype phenotype correlations. In our preliminary data we have: 1]
Secured resources to advance whole genome sequencing to evaluate our remaining unsolved cases.
2] Identified a further ten new genes as causes for PCH. 3] Remarkably, found that six of the novel
causes encode spliceosome proteins. 4] Uncovered R-loop accumulation as a cause of DNA damage
by which mutations lead to genotoxic stress. The goal of this application is to: 1] Identify the remaining
‘discoverable’ genes for PCH. 2] Functionally validate mutations within a pathogenic framework. 3]
Test the hypothesis that PCH gene loss leads to neurons cell death through R-loop accumulation,
DNA damage and genotoxic stress. This work will lead to insight into causes and mechanisms of an
important cause of infantile encephalopathy, and uncover mechanisms of selective neuronal
vulnerability and pediatric neurodegeneration underlying developmental brain disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Origins of Brain Somatic Mosaicism in Developmental Brain Disease
-
批准号:10466904
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2021
-
负责人:JOSEPH G GLEESON
-
依托单位:
University of California San Diego Neuroscience Microscopy Imaging Core
-
批准号:10524688
-
项目类别:
-
资助金额:$15.64万
-
财政年份:2021
-
负责人:JOSEPH G GLEESON
-
依托单位:
Origins of Brain Somatic Mosaicism in Developmental Brain Disease
-
批准号:10299502
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2021
-
负责人:JOSEPH G GLEESON
-
依托单位:
Origins of Brain Somatic Mosaicism in Developmental Brain Disease
-
批准号:10669715
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2021
-
负责人:JOSEPH G GLEESON
-
依托单位:
Project I - Human genetics of meningomyelocele and risk mitigation by folic acid
-
批准号:10300070
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Developmental Mechanisms of Human Meningomyelocele
-
批准号:10533735
-
项目类别:
-
资助金额:$139.06万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Developmental Mechanisms of Human Meningomyelocele
-
批准号:10300066
-
项目类别:
-
资助金额:$139.06万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Core A - Administrative Core
-
批准号:10533736
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Developmental Mechanisms of Human Meningomyelocele
-
批准号:10154461
-
项目类别:
-
资助金额:$141.71万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Core A - Administrative Core
-
批准号:10154462
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Core A - Administrative Core
-
批准号:10300067
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Project I - Human genetics of meningomyelocele and risk mitigation by folic acid
-
批准号:10533744
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Project I - Human genetics of meningomyelocele and risk mitigation by folic acid
-
批准号:10154465
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2020
-
负责人:JOSEPH G GLEESON
-
依托单位:
Molecular basis of Zika-induced microcephaly
-
批准号:10220150
-
项目类别:
-
资助金额:$55.7万
-
财政年份:2018
-
负责人:JOSEPH G GLEESON
-
依托单位:
Molecular basis of Zika-induced microcephaly
-
批准号:9791015
-
项目类别:
-
资助金额:$53.73万
-
财政年份:2018
-
负责人:JOSEPH G GLEESON
-
依托单位:
Molecular Characterization of Pontocerebellar Hypoplasia
-
批准号:10367043
-
项目类别:
-
资助金额:$47.37万
-
财政年份:2016
-
负责人:JOSEPH G GLEESON
-
依托单位:
Mosaicism in focal cortical dysplasias spectrum seen in neuropsychiatric disease
-
批准号:9249183
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2015
-
负责人:JOSEPH G GLEESON
-
依托单位:
Mosaicism in focal cortical dysplasias spectrum seen in neuropsychiatric disease
-
批准号:9905189
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2015
-
负责人:JOSEPH G GLEESON
-
依托单位:
Mosaicism in focal cortical dysplasias spectrum seen in neuropsychiatric disease
-
批准号:9147013
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2015
-
负责人:JOSEPH G GLEESON
-
依托单位:
Mosaicism in focal cortical dysplasias spectrum seen in neuropsychiatric disease
-
批准号:9392423
-
项目类别:
-
资助金额:$54.53万
-
财政年份:2015
-
负责人:JOSEPH G GLEESON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: